Centrose is applying scientific breakthroughs in novel sugar chemistry in order to discover, develop and commercialize small molecule therapeutics. Centrose expects therapeutics containing its novel sugar attachments will have far fewer failures and thus move quicker through the development pipeline.
Sugars are critical molecules that regulate biological processes and pathways in the human body and play fundamental roles in diseases as well as in drug action. Additionally, compounds that once did not contain sugar attachments have been found to have novel therapeutic properties after sugar addition.
